Gunnar Manum, the chief financial officer of Clavis Pharma ASA, has been appointed acting chief executive of the company following the departure of Olav Hellebø. This follows the failure of two cancer products that were in late-stage clinical development.
Clavis announced the appointment on 22 May 2013.
Copyright 2013 Evernow Publishing Ltd